MedDataX Logo

Clinical and Radiological Evaluation of Acoustic Neuromas With Spontaneous Shrinkage

NCT ID: NCT03970681

Last Updated: 2019-05-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-05-29

Study Completion Date

2020-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the regression characteristics of this Acoustic Neuroma population using volumetric data To study the relationship between regression and clinical characteristics including tinnitus, dizziness, hearing loss, and the intrinsic characteristics of the patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuroma, Acoustic

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Acoustic neuroma Vestibular schwannoma Spontaneous shrinkage Neoplasm regression Volume quantification Tridimensional measurements Volumetric measurements

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major subject (≥18 years old)
* Subject followed in radiology for the assessment or follow-up of neuroma between January 01, 2013 and June 30, 2018
* Subject who has agreed to the use of his data for the purpose of this research
* Subject presenting an untreated neuroma

Exclusion Criteria

* Subject having expressed his opposition to participating in the study
* Subject followed for neuroma of other cranial pairs,
* Subject followed in the context of type II neurofibromatosis
* Subject with a treated neuroma (radiotherapy or surgery)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service D'Orl Et de Chirurgie Cervico-Faciale

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Anne CHARPIOT, MD, PhD

Role: CONTACT

Phone: 33 3 88 12 76 49

Email: [email protected]

Guillaume TRAU, MD

Role: CONTACT

Phone: 33 3 88 12 76 49

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Anne CHARPIOT, MD, PhD

Role: primary

Guillaume TRAU, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

7417

Identifier Type: -

Identifier Source: org_study_id